Bull
$179.14
情景价格
$172.980
-0.554 (-0.32%)收盘时
The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at approximately 396 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. The Company's healthcare facilities include over 48 senior living operations across 17 states. The Company's segments include skilled services and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment consists of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. The Company's subsidiaries, including Standard Bearer, own approximately 181 real estate assets.
Ensign Group Inc is a good buy right now due to its strong recent earnings performance, with a Q2 2026 EPS of $1.92, exceeding expectations by $0.07, and a significant revenue growth of 18.0% year-over-year, reaching $1.44 billion. Additionally, the forward P/E ratio of 23.36 suggests that the stock is reasonably valued given its growth prospects, especially with analysts projecting a price target of $228, which represents a potential upside of 31.5% from the current price of $172.98. However, a notable risk is the ongoing investigation by Rosen Law Firm into potential securities claims, which could impact investor sentiment and stock performance.
RBC Capital
$228
2026-07-28
RBC Capital
2026-07-28
目标价
$228
RBC Capital
$222
2026-02-09
RBC Capital
2026-02-09
目标价
$222
UBS
$230
2026-02-06
UBS
2026-02-06
目标价
$230
Truist
$215
2026-02-06
Truist
2026-02-06
目标价
$215
RBC Capital
$206
2025-11-14
RBC Capital
2025-11-14
目标价
$206
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Rosen Law Firm Investigates Securities Claims Against Ensign Group

Significant Increase in Options Trading Volume

Rosen Law Firm Investigates Securities Claims Against Ensign Group

Rosen Law Firm Investigates Securities Claims Against Ensign Group

Rosen Law Firm Investigates Securities Claims Against Ensign Group
The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at approximately 396 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. The Company's healthcare facilities include over 48 senior living operations across 17 states. The Company's segments include skilled services and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment consists of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. The Company's subsidiaries, including Standard Bearer, own approximately 181 real estate assets. It operates in the Healthcare sector (SERVICES-SKILLED NURSING CARE FACILITIES industry).
Ensign Group Inc is a good buy right now due to its strong recent earnings performance, with a Q2 2026 EPS of $1.92, exceeding expectations by $0.07, and a significant revenue growth of 18.0% year-over-year, reaching $1.44 billion. Additionally, the forward P/E ratio of 23.36 suggests that the stock is reasonably valued given its growth prospects, especially with analysts projecting a price target of $228, which represents a potential upside of 31.5% from the current price of $172.98. However, a notable risk is the ongoing investigation by Rosen Law Firm into potential securities claims, which could impact investor sentiment and stock performance.
7 analysts cover ENSG: 5 rate it Buy, 1 Hold and 1 Sell. The average price target is 209.00.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。